French botanicals giant Naturex said first half results had been dented by a difficult macroeconomic environment and exchange rates, despite restructuring and acquisition moves.
Danisco has nudged up its full year outlook after a strong Q2, and is cautiously positive that mitigation measures will protect its enablers division from the raw material hikes on the horizon.
Naturex’s has indicated that the first six months of 2010 have brought strong revenue-growth as it set about integrating the ingredients division recently acquired from Natraceutical, but all its business arms contributed to the fine results.
Despite reporting a decline in revenues, Germany's third-largest
chemicalscompany Degussa said that it had 'got off to a solid
start' in the firstquarter of the year, ahead of presenting its
full results tomorrow.
Lonza CEO Markus Gemuend said today he will step down as the group
announced profits had fallen by 59 per cent on the previous year
and a 'major setback' in performance.
The German pharmaceuticals group reports that sales in the first
six months of 2002 rose 21 per cent on the previous year to €3.7
billion while operating income showed growth of 48 per cent to €495
million. Business in the US was...
US-based Lifeway Foods reported second quarter revenues of $3
million (€3.03), an increase of 9 per cent on the same period last
year. The success continues the strong trend seen this year by the
functional foods manufacturer.